May 21, 2021. Student nurse Dario Gomez, center, disinfects a chair after administering the Pfizer COVID-19 vaccine to a patient at Providence Edwards Lifesciences vaccination site in Santa Ana, Calif. U.S.AP Photo/Jae C. Hong

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

More good vaccine news is here: According to new data, the Pfizer coronavirus vaccine has “high levels of effectiveness” against the highly transmissible variant found in India. The data, from Public Health England, an agency in the UK department of health, studied Pfizer’s efficacy after two doses and found it was 88 percent effective in preventing symptomatic cases of the B.1.617.2 variant. 

Researchers found that the Pfizer shot is also highly effective against B.117, the variant first found in the UK, preventing 93 percent of symptomatic cases. And as with other variants, “even higher levels of effectiveness are expected against hospitalisation and death” after the second dose, according to the UK officials. Researchers also studied the effectiveness of the AstraZeneca vaccine, which has been used widely in the UK but has not yet been approved in the US; data shows it was was 60 percent effective against the B.1.617.2 variant, and 66 percent effective against B.117.

While the number of coronavirus cases and deaths have dropped in the United States as more people get vaccinated, the pandemic is not over yet. Other countries across the world are seeing the opposite trajectory, with more deaths and more confirmed cases. As Saturday’s announcement confirmed the efficacy of the vaccines against new variants, we passed the 165 million mark of coronavirus cases worldwide. Data from Johns Hopkins University shows that globally almost 3.5 million people have died from the virus. 

WE'LL BE BLUNT:

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't find elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

WE'LL BE BLUNT

We need to start raising significantly more in donations from our online community of readers, especially from those who read Mother Jones regularly but have never decided to pitch in because you figured others always will. We also need long-time and new donors, everyone, to keep showing up for us.

In "It's Not a Crisis. This Is the New Normal," we explain, as matter-of-factly as we can, what exactly our finances look like, how brutal it is to sustain quality journalism right now, what makes Mother Jones different than most of the news out there, and why support from readers is the only thing that keeps us going. Despite the challenges, we're optimistic we can increase the share of online readers who decide to donate—starting with hitting an ambitious $300,000 goal in just three weeks to make sure we can finish our fiscal year break-even in the coming months.

Please learn more about how Mother Jones works and our 47-year history of doing nonprofit journalism that you don't elsewhere—and help us do it with a donation if you can. We've already cut expenses and hitting our online goal is critical right now.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate